RaySearch appoints Antony Lomax as Clinical Ambassador Particle Therapy
The pioneer in proton therapy will strengthen RaySearch's strategic development in particle therapy.
See the latest news and media coverage for RaySearch. We track all announcements, press releases, and industry mentions in real time, all in one place.
Radiation therapy and oncology software provider
raysearchlabs.comLast updated
In short: RaySearch Laboratories achieved record 2025 revenue, expanded its particle therapy portfolio, and reached a target EBIT margin of 23 percent in Q1.
The pioneer in proton therapy will strengthen RaySearch's strategic development in particle therapy.
Resolutions include board re-elections, SEK 4 per share dividend, auditor re-election, LTI 2026 approval, and share buyback authorization.
Order intake fell 13% to SEK 356M, net sales 12% to SEK 290M. EBIT margin stable at 23%. New 30% margin target for 2028 announced.
The order, received in Q1 2026, marks RaySearch's first RayCare sale in France. It replaces existing systems to unify workflows across diverse treatment machines and enable adaptive radiotherapy.
Detailed price information for Raysearch Labs Ab Ord (RSLBF) from The Globe and Mail including charting and trades.
RaySearch Laboratories AB (publ) is pleased to announce that Iridium Network in Belgium has successfully completed its first online adaptive radiation treatment using RayStation®* and...
The Annual General Meeting 2026 of RaySearch Laboratories AB (publ) was held on May 7, 2026 in Stockholm, Sweden. The following resolutions were adopted. It...
Detailed price information for Raysearch Labs Ab Ord (RSLBF) from The Globe and Mail including charting and trades.
Track RaySearch and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to RaySearch and other trending companies.